Noticias de Eulerpool Akeso

Akeso Noticias de Acciones

Akeso es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Akeso.

• 5 de junio ·

  Yahoo
  Akeso gains NMPA approval for cadonilimab to treat cervical cancer
• 5 de junio ·

  Yahoo
  Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations--Third Approved Indication for Cadonilimab
• 3 de junio ·

  SeekingAlpha
  Explaining Summit's Fall Despite Positive Data In EGFR-Positive Lung Cancer
• 2 de junio ·

  Yahoo
  Bristol to Pay BioNTech Up to $11.1 Billion in Cancer Deal
• 9 de mayo ·

  SeekingAlpha
  Biotech Outperformance - Can't Take What's Already Earned
• 8 de mayo ·

  SeekingAlpha
  BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit
• 2 de mayo ·

  Yahoo
  Summit Therapeutics Q1 Loss Narrower Than Expected, Sales Nil
• 26 de abril ·

  SeekingAlpha
  Summit Therapeutics: New Ivonescimab Data Raise Concerns
• 20 de abril ·

  SeekingAlpha
  Bullish On Akeso's Ivonescimab, But Valuation And Geopolitical Risks Remain
• 21 de febrero ·

  Yahoo
  Akeso Enrolled First Patient in The Phase III Clinical Trial of Ivonescimab in Combination with Chemotherapy for First-Line Treatment of Triple-Negative Breast Cancer